ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Breast Cancer

Prostate Cancer trials near Salt Lake City, UT, USA:

Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Sumitomo Pharma
Sumitomo Pharma

Murray, Utah, United States and 107 other locations

The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...

Enrolling
Prostate Cancer
Drug: Piflufolastat F 18 Intravenous Solution [PYLARIFY]

Phase 4

Lantheus Medical Imaging
Lantheus Medical Imaging

Salt Lake City, Utah, United States and 9 other locations

Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110

Phase 1, Phase 2

Arvinas
Arvinas

Salt Lake City, Utah, United States and 53 other locations

Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...

Enrolling
Prostate Cancer
Drug: Abiraterone
Drug: Enzalutamide

Phase 1

Amgen
Amgen

Murray, Utah, United States and 50 other locations

the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Drug: Darolutamide (Nubeqa®) 300 mg tablets
Drug: ORIC-944

Phase 1

Oric Pharmaceuticals

Salt Lake City, Utah, United States and 12 other locations

plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...

Active, not recruiting
Prostate Cancer
Drug: Prednisone
Drug: Placebo

Phase 2, Phase 3

Lilly
Lilly

Salt Lake City, Utah, United States and 113 other locations

This study evaluates the diagnostic performance and safety of \[18F\]PSMA-1007 PET/CT imaging in patients with suspected recurrence of prostate...

Active, not recruiting
Prostate Cancer Recurrent
Prostate Cancer
Drug: [18F]PSMA-1007

Phase 3

ABX Advanced Biochemical Compounds

Salt Lake City, Utah, United States and 5 other locations

The purpose of this study is to determine how well the study drug XL092 is helping to treat a participant's cancer after 16 weeks of treatme...

Begins enrollment in 1 month
Metastatic Castration-resistant Prostate Cancer
Drug: XL092

Phase 2

Utah System of Higher Education (USHE)
Utah System of Higher Education (USHE)

Salt Lake City, Utah, United States

This is an open-label, phase II umbrella trial assessing the anti-tumor activity of enfortumab alone and in combination with other anti-cancer...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Enfortumab vedotin

Phase 2

Utah System of Higher Education (USHE)
Utah System of Higher Education (USHE)

Salt Lake City, Utah, United States

The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

Enrolling
Prostatic Neoplasms
Prostate Cancer
Drug: 64Cu-SAR-bisPSMA

Phase 3

Clarity Pharmaceuticals

Murray, Utah, United States and 14 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems